The Recall Desk
SevereFDA (Drugs)·D-1656-2019·Announced 2019-08-14

RXQ Compounding Recalls Epinephrine Infusion Bags Due to Sterility Concerns

RXQ Compounding LLC is recalling Epinephrine 4mg in D5W 5% infusion bags because the agency could not ensure the product was sterile.

What this means for you

Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.

Our severity reasoning: The recall is classified as FDA Class II, which corresponds to a Severe severity score according to the rubric for significant injury risks or Class II classifications.

Plain-English summary

RXQ Compounding LLC is recalling Epinephrine 4mg added to D5W 5%, 250 mL per bag (NDC: 70731-0113-22). The recall was initiated because the company could not provide assurance that the product was sterile.

The affected product was distributed nationwide in the United States. The recall includes all lots within their expiration dates.

Consumers and healthcare providers should stop using the recalled product and contact their healthcare provider or the recalling firm for further instructions.

The recalled product

Product
EPINEPHrine 4MG ADDED TO D5W 5%, 250 ML per bag, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0113-22
Manufacturer
RXQ Compounding LLC
Category
Drug — Infusion Solution
Hazard

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (1)

  • All lots within expiry

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 86 recalled by RXQ Compounding LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 86 products in this recall →

Related recalls

Same manufacturer · RXQ Compounding LLC

See all →

Same hazard · sterility

See all →